Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F89HE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,042
Award facts
- Contract value 100% obligated
- $13,042.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,042.44 delivery order to Amerisourcebergen Drug Corp on April 13, 2026, for HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL.
The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 14, 2026. Pricing is firm fixed price with no set-aside used.
Quick answers
Who was awarded contract SPE2DR26F89HE?
SPE2DR26F89HE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 13, 2026.
How much is contract SPE2DR26F89HE worth?
The government has obligated $13,042 on SPE2DR26F89HE.
Is contract SPE2DR26F89HE an order under another contract?
Yes. SPE2DR26F89HE is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F89HE competed?
The extent of competition for SPE2DR26F89HE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award